Ibtrozi

Active Ingredient(s): Taletrectinib Adipate
FDA Approved: * June 11, 2025
Pharm Company: * NUVATION
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Ibtrozi 272 mg Oral Capsule
NDC: 84651-200
Labeler:
Nuvation Bio Inc.